The study is a non-interventional evaluation of participants with SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA biomarker profiling in addition to their standard of care therapy and disease surveillance.
Small Cell Lung Cancer
The study is a non-interventional evaluation of participants with SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA biomarker profiling in addition to their standard of care therapy and disease surveillance.
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
-
Cancer and Blood Specialty Clinic, Los Alamitos, California, United States, 90720
University of Colorado, Aurora, Colorado, United States, 80045
Illinois Cancer Care, Peoria, Illinois, United States, 61615
Johns Hopkins University, Baltimore, Maryland, United States, 21287
Englewood Health Medical Center, Englewood, New Jersey, United States, 07631
University of North Carolina, Chapel Hill, North Carolina, United States, 27599
TriHealth Cancer Institute, Cincinnati, Ohio, United States, 45220
Ohio State University, Columbus, Ohio, United States, 43210
OhioHealth Research Institute, Columbus, Ohio, United States, 43214
Oklahoma Cancer Specialists and Research Institutes, Tulsa, Oklahoma, United States, 74146
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Tempus AI,
Virginia Rhodes, MD, PRINCIPAL_INVESTIGATOR, Tempus AI, Inc.
2026-03